Across TCGA pan-cancer cohorts, RPS11P7 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS11P7’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS11P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS11P7 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

COAD, LIHC, and THCA are the cancer types where RPS11P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS11P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.897	<.001	10	view →
LIHC	Female	II,III,IV	+0.174	<.001	4	view →
THCA	Male	All	−0.172	.005	3	view →
KICH	All	II,III,IV	−0.120	.038	2	view →
PRAD	All	All	+0.108	.045	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS11P7 RNA expression & survival · all RPS11P7 data types